Progression to active tuberculosis, but not transmission, varies by Mycobacterium tuberculosis lineage in the Gambia

被引:231
作者
de Jong, Bouke C. [1 ,2 ]
Hill, Philip C. [1 ]
Aiken, Alex [1 ]
Awine, Timothy [1 ]
Antonio, Martin [1 ]
Adetifa, Ifedayo M. [1 ]
Jackson-Sillah, Dolly J. [1 ]
Fox, Annette [1 ]
DeRiemer, Kathryn [3 ]
Gagneux, Sebastien [4 ]
Borgdorff, Martien W. [5 ,6 ]
McAdam, Keith P. W. J. [1 ]
Corrah, Tumani [1 ]
Small, Peter M. [4 ]
Adegbola, Richard A. [1 ]
机构
[1] MRC Labs, Bacterial Dis Programme, Banjul, Gambia
[2] Stanford Univ, Stanford, CA 94305 USA
[3] Univ Calif Davis, Davis, CA 95616 USA
[4] Inst Syst Biol, Seattle, WA USA
[5] Univ Amsterdam, Amsterdam, Netherlands
[6] Royal Netherlands TB Assoc, The Hague, Netherlands
基金
英国医学研究理事会;
关键词
D O I
10.1086/591504
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Background. There is considerable variability in the outcome of Mycobacterium tuberculosis infection. We hypothesized that Mycobacterium africanum was less likely than M. tuberculosis to transmit and progress to tuberculosis disease. Methods. In a cohort study of patients with tuberculosis and their household contacts in The Gambia, we categorized 1808 HIV-negative tuberculosis contacts according to exposure to M. tuberculosis or M. africanum. Positive skin test results indicated transmission, and development of tuberculosis during 2 years of follow-up indicated progression to disease. Results. Transmission rates were similar, but rates of progression to disease were significantly lower in contacts exposed to M. africanum than in those exposed to M. tuberculosis (1.0% vs. 2.9%; hazard ratio [HR], 3.1 [95% confidence interval {CI}, 1.1 - 8.7]). Within M. tuberculosis sensu stricto, contacts exposed to a Beijing family strain were most likely to progress to disease (5.6%; HR relative to M. africanum, 6.7 [95% CI, 2.0 - 22]). Conclusions. M. africanum and M. tuberculosis transmit equally well to household contacts, but contacts exposed to M. africanum are less likely to progress to tuberculosis disease than those exposed to M. tuberculosis. The variable rate of progression by lineage suggests that tuberculosis variability matters in clinical settings and should be accounted for in studies evaluating tuberculosis vaccines and treatment regimens for latent tuberculosis infection.
引用
收藏
页码:1037 / 1043
页数:7
相关论文
共 28 条
[21]   Effects of genetic variability of Mycobacterium tuberculosis strains on the presentation of disease [J].
Malik, AN ;
Godfrey-Faussett, P .
LANCET INFECTIOUS DISEASES, 2005, 5 (03) :174-183
[22]   Recombinant BCG exporting ESAT-6 confers enhanced protection against tuberculosis [J].
Pym, AS ;
Brodin, P ;
Majlessi, L ;
Brosch, R ;
Demangel, C ;
Williams, A ;
Griffiths, KE ;
Marchal, G ;
Leclerc, C ;
Cole, ST .
NATURE MEDICINE, 2003, 9 (05) :533-539
[23]   A glycolipid of hypervirulent tuberculosis strains that inhibits the innate immune response [J].
Reed, MB ;
Domenech, P ;
Manca, C ;
Su, H ;
Barczak, AK ;
Kreiswirth, BN ;
Kaplan, G ;
Barry, CE .
NATURE, 2004, 431 (7004) :84-87
[24]   THE EPIDEMIOLOGY OF TUBERCULOSIS IN SAN-FRANCISCO - A POPULATION-BASED STUDY USING CONVENTIONAL AND MOLECULAR METHODS [J].
SMALL, PM ;
HOPEWELL, PC ;
SINGH, SP ;
PAZ, A ;
PARSONNET, J ;
RUSTON, DC ;
SCHECTER, GF ;
DALEY, CL ;
SCHOOLNIK, GK .
NEW ENGLAND JOURNAL OF MEDICINE, 1994, 330 (24) :1703-1709
[25]   Functional and evolutionary genomics of Mycobacterium tuberculosis:: Insights from genomic deletions in 100 strains [J].
Tsolaki, AG ;
Hirsh, AE ;
DeRiemer, K ;
Enciso, JA ;
Wong, MZ ;
Hannan, M ;
de la Salmoniere, YOL ;
Aman, K ;
Kato-Maeda, M ;
Small, PM .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2004, 101 (14) :4865-4870
[26]   An outbreak involving extensive transmission of a virulent strain of Mycobacterium tuberculosis [J].
Valway, SE ;
Sanchez, MPC ;
Shinnick, TF ;
Orme, I ;
Agerton, T ;
Hoy, D ;
Jones, JS ;
Westmoreland, H ;
Onorato, IM .
NEW ENGLAND JOURNAL OF MEDICINE, 1998, 338 (10) :633-639
[27]   Inhibition of respiration by nitric oxide induces a Mycobacterium tuberculosis dormancy program [J].
Voskuil, MI ;
Schnappinger, D ;
Visconti, KC ;
Harrell, MI ;
Dolganov, GM ;
Sherman, DR ;
Schoolnik, GK .
JOURNAL OF EXPERIMENTAL MEDICINE, 2003, 198 (05) :705-713
[28]  
*WHO, 2007, 2007 TUB FACTS